Literature DB >> 23787392

Application of the international prognostic scoring system-revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia.

C Y Ok1, R P Hasserjian2, P S Fox3, F Stingo3, Z Zuo1, K H Young1, K Patel1, L J Medeiros1, G Garcia-Manero4, S A Wang1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23787392     DOI： 10.1038/leu.2013.191

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

1.  Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases.

Authors:  M T Voso; E Fabiani; L Fianchi; G Falconi; M Criscuolo; R Santangelo; P Chiusolo; S Betti; F D'Alo'; S Hohaus; V De Stefano; G Leone
Journal:  Leukemia       Date:  2012-09-11       Impact factor: 11.528

2.  Revised international prognostic scoring system for myelodysplastic syndromes.

Authors:  Peter L Greenberg; Heinz Tuechler; Julie Schanz; Guillermo Sanz; Guillermo Garcia-Manero; Francesc Solé; John M Bennett; David Bowen; Pierre Fenaux; Francois Dreyfus; Hagop Kantarjian; Andrea Kuendgen; Alessandro Levis; Luca Malcovati; Mario Cazzola; Jaroslav Cermak; Christa Fonatsch; Michelle M Le Beau; Marilyn L Slovak; Otto Krieger; Michael Luebbert; Jaroslaw Maciejewski; Silvia M M Magalhaes; Yasushi Miyazaki; Michael Pfeilstöcker; Mikkael Sekeres; Wolfgang R Sperr; Reinhard Stauder; Sudhir Tauro; Peter Valent; Teresa Vallespi; Arjan A van de Loosdrecht; Ulrich Germing; Detlef Haase
Journal:  Blood       Date:  2012-06-27       Impact factor: 22.113

3.  Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant.

Authors:  Zeba N Singh; Dezheng Huo; John Anastasi; Sonali M Smith; Theodore Karrison; Michelle M Le Beau; Richard A Larson; James W Vardiman
Journal:  Am J Clin Pathol       Date:  2007-02       Impact factor: 2.493

4.  Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.

Authors:  Ulrike Bacher; Claudia Haferlach; Tamara Alpermann; Wolfgang Kern; Susanne Schnittger; Torsten Haferlach
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

5.  Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.

Authors:  N Mauritzson; M Albin; L Rylander; R Billström; T Ahlgren; Z Mikoczy; J Björk; U Strömberg; P G Nilsson; F Mitelman; L Hagmar; B Johansson
Journal:  Leukemia       Date:  2002-12       Impact factor: 11.528

6.  Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

Authors:  Jay P Patel; Mithat Gönen; Maria E Figueroa; Hugo Fernandez; Zhuoxin Sun; Janis Racevskis; Pieter Van Vlierberghe; Igor Dolgalev; Sabrena Thomas; Olga Aminova; Kety Huberman; Janice Cheng; Agnes Viale; Nicholas D Socci; Adriana Heguy; Athena Cherry; Gail Vance; Rodney R Higgins; Rhett P Ketterling; Robert E Gallagher; Mark Litzow; Marcel R M van den Brink; Hillard M Lazarus; Jacob M Rowe; Selina Luger; Adolfo Ferrando; Elisabeth Paietta; Martin S Tallman; Ari Melnick; Omar Abdel-Wahab; Ross L Levine
Journal:  N Engl J Med       Date:  2012-03-14       Impact factor: 91.245

7.  Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at risk.

Authors:  Liang Li; Min Li; Canlan Sun; Liton Francisco; Sujata Chakraborty; Melanie Sabado; Tinisha McDonald; Janelle Gyorffy; Karen Chang; Shirong Wang; Wenhong Fan; Jiangning Li; Lue Ping Zhao; Jerald Radich; Stephen Forman; Smita Bhatia; Ravi Bhatia
Journal:  Cancer Cell       Date:  2011-11-15       Impact factor: 31.743

8.  New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.

Authors:  Julie Schanz; Heinz Tüchler; Francesc Solé; Mar Mallo; Elisa Luño; José Cervera; Isabel Granada; Barbara Hildebrandt; Marilyn L Slovak; Kazuma Ohyashiki; Christian Steidl; Christa Fonatsch; Michael Pfeilstöcker; Thomas Nösslinger; Peter Valent; Aristoteles Giagounidis; Carlo Aul; Michael Lübbert; Reinhard Stauder; Otto Krieger; Guillermo Garcia-Manero; Stefan Faderl; Sherry Pierce; Michelle M Le Beau; John M Bennett; Peter Greenberg; Ulrich Germing; Detlef Haase
Journal:  J Clin Oncol       Date:  2012-02-13       Impact factor: 44.544

9.  Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms.

Authors:  Valentina Nardi; Karen M Winkfield; Chi Young Ok; Andrzej Niemierko; Michael J Kluk; Eyal C Attar; Guillermo Garcia-Manero; Sa A Wang; Robert P Hasserjian
Journal:  J Clin Oncol       Date:  2012-05-14       Impact factor: 44.544

10.  Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML.

Authors:  C Schoch; W Kern; S Schnittger; W Hiddemann; T Haferlach
Journal:  Leukemia       Date:  2004-01       Impact factor: 11.528
View more
  19 in total

1.  Newly emerged isolated Del(7q) in patients with prior cytotoxic therapies may not always be associated with therapy-related myeloid neoplasms.

Authors:  Rashmi S Goswami; Sa A Wang; Courtney DiNardo; Zhenya Tang; Yan Li; Wenli Zuo; Shimin Hu; Shaoying Li; L Jeffrey Medeiros; Guilin Tang
Journal:  Mod Pathol       Date:  2016-04-08       Impact factor: 7.842

2.  Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies.

Authors:  C Cameron Yin; Jie Peng; Yu Li; Rashmi Kanagal-Shamanna; Tariq Muzzafar; Courtney DiNardo; Joseph D Khoury; Shaoying Li; L Jeffrey Medeiros; Sa A Wang; Guilin Tang
Journal:  Mod Pathol       Date:  2015-06-05       Impact factor: 7.842

3.  Is there a pressing need for improving prognostication strategies in therapy-related myelodysplastic syndromes?

Authors:  X Calvo; L Florensa; L Arenillas
Journal:  Leukemia       Date:  2017-07-31       Impact factor: 11.528

4.  Therapy-related myelodysplastic syndromes-specific risk stratification: are we putting the cart before the horse?

Authors:  A M Zeidan; M A Sekeres; J Barnard; D P Steensma; R Komrokji
Journal:  Leukemia       Date:  2017-07-31       Impact factor: 11.528

Review 5.  Myelodysplastic Syndromes: Updates and Nuances.

Authors:  Kim-Hien T Dao
Journal:  Med Clin North Am       Date:  2017-03       Impact factor: 5.456

Review 6.  Second malignancies in multiple myeloma; emerging patterns and future directions.

Authors:  Kylee Maclachlan; Benjamin Diamond; Francesco Maura; Jens Hillengass; Ingemar Turesson; C Ola Landgren; Dickran Kazandjian
Journal:  Best Pract Res Clin Haematol       Date:  2020-01-11       Impact factor: 3.020

Review 7.  A focused review of hematopoietic neoplasms occurring in the therapy-related setting.

Authors:  Liping Zhang; Sa A Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

8.  Myelodysplastic syndromes, version 2.2015.

Authors:  Peter L Greenberg; Richard M Stone; Rafael Bejar; John M Bennett; Clara D Bloomfield; Uma Borate; Carlos M De Castro; H Joachim Deeg; Amy E DeZern; Amir T Fathi; Olga Frankfurt; Karin Gaensler; Guillermo Garcia-Manero; Elizabeth A Griffiths; David Head; Virginia Klimek; Rami Komrokji; Lisa A Kujawski; Lori J Maness; Margaret R O'Donnell; Daniel A Pollyea; Bart Scott; Paul J Shami; Brady L Stein; Peter Westervelt; Benton Wheeler; Dorothy A Shead; Courtney Smith
Journal:  J Natl Compr Canc Netw       Date:  2015-03       Impact factor: 11.908

9.  High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome.

Authors:  Arjen H G Cleven; Valentina Nardi; Chi Young Ok; Maitrayee Goswami; Paola Dal Cin; Zongli Zheng; A John Iafrate; Myrurgia A Abdul Hamid; Sa A Wang; Robert P Hasserjian
Journal:  Mod Pathol       Date:  2014-11-21       Impact factor: 7.842

10.  Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.

Authors:  Chi Young Ok; Keyur P Patel; Guillermo Garcia-Manero; Mark J Routbort; Bin Fu; Guilin Tang; Maitrayee Goswami; Rajesh Singh; Rashmi Kanagal-Shamanna; Sherry A Pierce; Ken H Young; Hagop M Kantarjian; L Jeffrey Medeiros; Rajyalakshmi Luthra; Sa A Wang
Journal:  Leuk Res       Date:  2014-12-20       Impact factor: 3.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.